Measures of physical performance in COVID-19 patients: a mapping review.


Journal

Pulmonology
ISSN: 2531-0437
Titre abrégé: Pulmonology
Pays: Spain
ID NLM: 101723786

Informations de publication

Date de publication:
Historique:
received: 28 04 2021
revised: 10 06 2021
accepted: 11 06 2021
pubmed: 22 7 2021
medline: 15 12 2021
entrez: 21 7 2021
Statut: ppublish

Résumé

There is evidence of short- and long-term impairment of physical performance in patients with COVID-19 infection, but a verification of measures of physical impairment in this condition is lacking. We reviewed the measures used to assess physical performance in these patients. Secondary targets were measures of exercise or daily life activities induced symptoms. Medline, CINAHL, and Pedro databases were searched from January 2020 to February 2021 for articles in the English language. Two investigators independently conducted the search, screened all titles and/or abstracts based on the inclusion criteria and independently scored the studies. The quality of the studies was evaluated by two reviewers according to the NIH quality assessment tool for observational cohort and cross-sectional studies. Discrepancies were resolved through consensus. Out of 156 potentially relevant articles, 31 observational studies (8 cross-sectional), 1 randomized controlled trial, and 1 protocol were included. The quality of most of the 31 evaluable studies was judged as low (11 studies) or fair (14 studies). Sample sizes of the studies ranged from 14 to 20,889 patients. among the 28 reported measures, Barthel Index (42.4% of studies), Six-Minute Walking Distance Test (36.4%), Short Physical Performance Battery (21.2%) and 1-Minute Sit-to-Stand (12.1%) were the most used. Fifteen% and 36% of studies reported exercise induced desaturation and dyspnoea when performing the assessments, respectively. Other exercise induced symptoms were fatigue and pain. Studies reported wide ranges of impairment in physical performance as compared to "reference" values (range of mean or median reported values vs "reference values": 11-77 vs 100 points for Barthel Index; 11-22 vs 22-37 repetitions/min for 1m-STS; 0.5-7.9 vs 11.4 ± 1.3 points for SPPB; and 45-223 vs 380-782 m for 6MWT respectively). This review found that a wide variety of functional status tests have been used, making comparisons difficult between studies. These measures show impairment in physical performance in COVID-19 patients. However, the quality of most of the studies was judged as low or fair.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
There is evidence of short- and long-term impairment of physical performance in patients with COVID-19 infection, but a verification of measures of physical impairment in this condition is lacking. We reviewed the measures used to assess physical performance in these patients. Secondary targets were measures of exercise or daily life activities induced symptoms.
METHODS METHODS
Medline, CINAHL, and Pedro databases were searched from January 2020 to February 2021 for articles in the English language. Two investigators independently conducted the search, screened all titles and/or abstracts based on the inclusion criteria and independently scored the studies. The quality of the studies was evaluated by two reviewers according to the NIH quality assessment tool for observational cohort and cross-sectional studies. Discrepancies were resolved through consensus.
RESULTS RESULTS
Out of 156 potentially relevant articles, 31 observational studies (8 cross-sectional), 1 randomized controlled trial, and 1 protocol were included. The quality of most of the 31 evaluable studies was judged as low (11 studies) or fair (14 studies). Sample sizes of the studies ranged from 14 to 20,889 patients. among the 28 reported measures, Barthel Index (42.4% of studies), Six-Minute Walking Distance Test (36.4%), Short Physical Performance Battery (21.2%) and 1-Minute Sit-to-Stand (12.1%) were the most used. Fifteen% and 36% of studies reported exercise induced desaturation and dyspnoea when performing the assessments, respectively. Other exercise induced symptoms were fatigue and pain. Studies reported wide ranges of impairment in physical performance as compared to "reference" values (range of mean or median reported values vs "reference values": 11-77 vs 100 points for Barthel Index; 11-22 vs 22-37 repetitions/min for 1m-STS; 0.5-7.9 vs 11.4 ± 1.3 points for SPPB; and 45-223 vs 380-782 m for 6MWT respectively).
CONCLUSION CONCLUSIONS
This review found that a wide variety of functional status tests have been used, making comparisons difficult between studies. These measures show impairment in physical performance in COVID-19 patients. However, the quality of most of the studies was judged as low or fair.

Identifiants

pubmed: 34284976
pii: S2531-0437(21)00125-2
doi: 10.1016/j.pulmoe.2021.06.005
pmc: PMC8221906
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

518-528

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest NA is the Chief Editor of Pulmonology. The other authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Thorax. 1999 Jul;54(7):581-6
pubmed: 10377201
Eur J Phys Rehabil Med. 2021 Apr;57(2):208-215
pubmed: 33541042
Pulmonology. 2020 Jul - Aug;26(4):213-220
pubmed: 32362507
Pulmonology. 2021 Mar-Apr;27(2):97-106
pubmed: 33281107
Medicine (Baltimore). 2020 Nov 25;99(48):e23327
pubmed: 33235096
Chron Respir Dis. 2015 Aug;12(3):179-88
pubmed: 25749347
Respir Res. 2020 Oct 21;21(1):276
pubmed: 33087116
Arch Rehabil Res Clin Transl. 2021 Jun;3(2):100108
pubmed: 33558860
Respiration. 2021;100(5):416-422
pubmed: 33784696
Intensive Care Med. 2020 Nov;46(11):2083-2085
pubmed: 32986233
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618793028
pubmed: 30091679
Front Med (Lausanne). 2021 Jan 18;7:615997
pubmed: 33537333
Eur J Phys Rehabil Med. 2021 Jun;57(3):443-450
pubmed: 33393278
Eur J Intern Med. 2021 Jun;88:126-128
pubmed: 33741207
Ann Am Thorac Soc. 2017 May;14(5):778-784
pubmed: 28244799
Trials. 2020 Aug 27;21(1):751
pubmed: 32854761
Pulmonology. 2020 Sep - Oct;26(5):304-313
pubmed: 32184070
Respir Care. 2016 Dec;61(12):1620-1628
pubmed: 27899540
Ann Am Thorac Soc. 2021 Jun;18(6):997-1003
pubmed: 33413026
Syst Rev. 2016 Feb 10;5:28
pubmed: 26864942
J Clin Epidemiol. 1989;42(8):703-9
pubmed: 2760661
Mil Med Res. 2020 Feb 29;7(1):7
pubmed: 32111253
Respirology. 2018 Apr;23(4):392-398
pubmed: 29193512
Eur Respir J. 2020 Oct 15;56(4):
pubmed: 32764112
Forensic Sci Res. 2020 Jun 10;5(2):174-187
pubmed: 32939434
Int J Chron Obstruct Pulmon Dis. 2020 Oct 21;15:2591-2599
pubmed: 33116476
Eur J Phys Rehabil Med. 2021 Apr;57(2):199-207
pubmed: 33565741
PLoS One. 2021 Jan 22;16(1):e0245840
pubmed: 33481930
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Syst Rev. 2021 Mar 29;10(1):89
pubmed: 33781348
J Prev Med Hyg. 2020 Oct 06;61(3):E304-E312
pubmed: 33150219
Complement Ther Clin Pract. 2020 May;39:101166
pubmed: 32379637
Eur J Phys Rehabil Med. 2020 Oct;56(5):633-641
pubmed: 32667150
BMC Geriatr. 2019 Aug 8;19(1):216
pubmed: 31395008
Acad Radiol. 2020 Jul;27(7):910-921
pubmed: 32505599
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
BMC Med. 2020 Dec 18;18(1):408
pubmed: 33334341
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Am J Phys Med Rehabil. 2021 Feb 1;100(2):105-109
pubmed: 33181531
Arch Phys Med Rehabil. 2021 Jun;102(6):1228-1231
pubmed: 33529611
Am J Respir Crit Care Med. 2003 Nov 1;168(9):1084-90
pubmed: 12917227
Int J Chron Obstruct Pulmon Dis. 2015 Dec 03;10:2619-26
pubmed: 26664110
Pulmonology. 2020 Jul - Aug;26(4):204-212
pubmed: 32362505
JAMA Netw Open. 2021 Jan 4;4(1):e2036142
pubmed: 33502487
Eur J Phys Rehabil Med. 2021 Jun;57(3):434-442
pubmed: 33448757
Respir Med. 2020 Nov - Dec;174:106197
pubmed: 33120193
JAMA. 2021 May 18;325(19):2015-2016
pubmed: 33825846
Int J Public Health. 2013 Dec;58(6):949-53
pubmed: 23974352
Respir Med. 2007 Feb;101(2):286-93
pubmed: 16806873
Int J Infect Dis. 2020 Oct;99:100-101
pubmed: 32663601
BMC Anesthesiol. 2021 Mar 2;21(1):64
pubmed: 33653264
PLoS One. 2020 Dec 17;15(12):e0243883
pubmed: 33332386
Pulmonology. 2021 Sep-Oct;27(5):452-455
pubmed: 33454281
J Rehabil Med. 2020 Sep 4;52(9):jrm00095
pubmed: 32871014
Front Med (Lausanne). 2020 Jul 21;7:459
pubmed: 32793620
Chest. 2014 Aug;146(2):328-338
pubmed: 24722847
Pulmonology. 2021 Jul-Aug;27(4):328-337
pubmed: 33262076
Arch Phys Med Rehabil. 2021 Jun;102(6):1067-1074
pubmed: 33548208
Eur Respir J. 2011 Jan;37(1):150-6
pubmed: 20525717
Ann Intern Med. 2021 Mar;174(3):316-325
pubmed: 33226861
Respir Physiol Neurobiol. 2014 Jan 1;190:40-6
pubmed: 24121092
Eur J Phys Rehabil Med. 2021 Aug;57(4):653-662
pubmed: 33393277
Am J Epidemiol. 2008 May 1;167(9):1090-101
pubmed: 18343879
Eur J Phys Rehabil Med. 2021 Apr;57(2):189-198
pubmed: 33448756
Ann Am Thorac Soc. 2021 Jan;18(1):122-129
pubmed: 32915072
Respir Physiol Neurobiol. 2021 May;287:103639
pubmed: 33588090

Auteurs

Carla Simonelli (C)

Istituti Clinici Scientifici Maugeri IRCCS, Respiratory Rehabilitation Division of the Institute of Lumezzane, Via G Mazzini 129, 25065 Lumezzane (Brescia), Italy. Electronic address: carla.simonelli@icsmaugeri.it.

Mara Paneroni (M)

Istituti Clinici Scientifici Maugeri IRCCS, Respiratory Rehabilitation Division of the Institute of Lumezzane, Via G Mazzini 129, 25065 Lumezzane (Brescia), Italy. Electronic address: mara.paneroni@icsmaugeri.it.

Michele Vitacca (M)

Istituti Clinici Scientifici Maugeri IRCCS, Respiratory Rehabilitation Division of the Institute of Lumezzane, Via G Mazzini 129, 25065 Lumezzane (Brescia), Italy. Electronic address: michele.vitacca@icsmaugeri.it.

Nicolino Ambrosino (N)

Istituti Clinici Scientifici Maugeri IRCCS, Respiratory Rehabilitation Division of the Institute of Montescano, Pavia, Italy. Electronic address: nico.ambrosino@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH